Form 4: SeaStar Medical Director Granted Restricted Stock Units

SeaStar Medical Holding Corp. Director Jennifer A. Baird was granted 4,000 restricted stock units, vesting fully by July 3, 2026.

Summary

• Jennifer A. Baird, a Director of SeaStar Medical Holding Corp. (ICU), was granted 4,000 shares of Common Stock.
• These shares are in the form of Restricted Stock Units (RSUs), which were acquired at a price of $0 per share.
• The RSU award transaction date was July 10, 2025.
• The RSUs are scheduled to vest in full on July 3, 2026.
• Following this transaction, Jennifer A. Baird beneficially owns a total of 32,000 shares of SeaStar Medical Holding Corp. common stock.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally positive as it aligns interests and is a standard compensation practice, indicating continued commitment. No negative information is present in this filing.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their long-term interests with those of shareholders, promoting commitment to the company's future performance.
• The increase in the director's beneficial ownership demonstrates continued investment and confidence in the company.

Future Outlook

The Restricted Stock Units granted to Director Jennifer A. Baird are scheduled to vest in full on July 3, 2026, representing a future milestone for this equity compensation.

Industry Context

This transaction represents a standard equity compensation event for a director, a common practice across all industries to incentivize and retain key personnel. It does not provide specific insights into broader industry trends.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a standard form of equity compensation in publicly traded companies across various industries.
• This mechanism is commonly used by companies in the medical device and biotech sectors, such as Medtronic (MDT) or Boston Scientific (BSX), to align director incentives with long-term shareholder value and is considered a routine aspect of corporate governance and compensation practices.

Related Party Transactions

• Grant of 4,000 Restricted Stock Units (RSUs) to Jennifer A. Baird, a Director of SeaStar Medical Holding Corp., as part of her compensation package.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's long-term interests with shareholder value creation, as the value of the RSUs is tied to the company's stock performance.

Next Steps

• The Restricted Stock Units are scheduled to vest in full on July 3, 2026.

Key Dates

Recommendation

Keywords

SeaStar Medical, ICU, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant